ING Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-22,049
Closed -$4.05M 611
2021
Q2
$4.05M Buy
22,049
+7,493
+51% +$1.38M 0.06% 188
2021
Q1
$2.23M Buy
14,556
+40
+0.3% +$6.12K 0.05% 229
2020
Q4
$2.27M Buy
14,516
+9,665
+199% +$1.51M 0.05% 224
2020
Q3
$555K Buy
4,851
+2,983
+160% +$341K 0.02% 282
2020
Q2
$210K Buy
+1,868
New +$210K 0.01% 271
2020
Q1
Sell
-15,179
Closed -$1.64M 515
2019
Q4
$1.64M Buy
15,179
+1,186
+8% +$128K 0.05% 230
2019
Q3
$1.37M Sell
13,993
-136,362
-91% -$13.4M 0.03% 258
2019
Q2
$19.7M Buy
+150,355
New +$19.7M 0.34% 58
2019
Q1
Sell
-26,840
Closed -$2.61M 849
2018
Q4
$2.61M Buy
26,840
+5,416
+25% +$527K 0.06% 198
2018
Q3
$2.98M Buy
+21,424
New +$2.98M 0.05% 215
2018
Q2
Sell
-19,333
Closed -$2.16M 876
2018
Q1
$2.16M Sell
19,333
-33,994
-64% -$3.79M 0.04% 206
2017
Q4
$6.38M Buy
53,327
+3,445
+7% +$412K 0.11% 101
2017
Q3
$7M Buy
49,882
+40,410
+427% +$5.67M 0.13% 115
2017
Q2
$1.15M Buy
9,472
+1,215
+15% +$148K 0.02% 298
2017
Q1
$1M Buy
+8,257
New +$1M 0.02% 339
2016
Q1
Sell
-86,239
Closed -$16.4M 713
2015
Q4
$16.4M Buy
86,239
+3,997
+5% +$762K 0.1% 184
2015
Q3
$12.8M Buy
+82,242
New +$12.8M 0.09% 179
2015
Q2
Sell
-35,731
Closed -$6.19M 761
2015
Q1
$6.19M Buy
35,731
+171
+0.5% +$29.6K 0.03% 358
2014
Q4
$6.59M Buy
35,560
+7,000
+25% +$1.3M 0.03% 346
2014
Q3
$4.74M Sell
28,560
-382
-1% -$63.3K 0.03% 364
2014
Q2
$4.52M Sell
28,942
-4,356
-13% -$681K 0.02% 372
2014
Q1
$5.08M Buy
33,298
+3,332
+11% +$508K 0.03% 364
2013
Q4
$3.98M Buy
29,966
+971
+3% +$129K 0.02% 388
2013
Q3
$3.36M Sell
28,995
-14,439
-33% -$1.68M 0.02% 436
2013
Q2
$4.01M Buy
+43,434
New +$4.01M 0.02% 389